Shortly before adjourning, the Minnesota legislature cleared and sent to the governor legislation to bar 340B contract pharmacy access restrictions [...] …
Category: State
Ohio is the latest state to consider proposed legislation that would ban drugmakers from restricting covered entities’ acquisition of 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A new political action committee (PAC) targeting Republican lawmakers that support 340B legislation spent $400,000 in a key West Virginia [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Virginia Gov. Glenn Youngkin (R) late Friday vetoed a bill that would have prohibited drugmaker contract pharmacy restrictions on grantee [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
On the final day of Missouri’s legislative session, lawmakers overwhelmingly passed a bill to bar drugmaker 340B contract pharmacy restrictions [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Maryland Gov. Wes Moore (D) this morning is signing legislation to make Maryland the sixth state to prohibit drugmaker 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge scheduled an April 2025 trial date for AstraZeneca’s lawsuit against Arkansas’ 340B contract pharmacy access law as [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
This week will see major legislative action on up to four state 340B contract pharmacy access bills—including on two controversial [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
With less than two weeks remaining in the Missouri legislative session, two key house committees approved a 340B contract pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
North Carolina hospitals that participate in the 340B program routinely overcharged cancer patients, taxpayers and state employees for oncology drugs, [...] …
